SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zydus Lifesciences - Quaterly Results

03 Feb 2023 Evaluate
The revenue zoomed 14.02% to Rs. 20869.00 millions for the quarter ended December 2022 as compared to Rs. 18303.00 millions during the corresponding quarter last year.The company has announced a 29.90% increase in its profits to Rs . 2559.00  millions for the  quarter ended December 2022 compared to Rs. 1970.00 millions in the corresponding quarter in the previous year.OP of the company witnessed a marginal growth to 5949.00 millions from 3845.00 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 20869.00 18303.00 14.02 64666.00 59626.00 8.45 79819.00 77800.00 2.60
Other Income 1363.00 259.00 426.25 2972.00 1250.00 137.76 1787.00 893.00 100.11
PBIDT 5949.00 3845.00 54.72 19791.00 15855.00 24.82 20968.00 23980.00 -12.56
Interest 885.00 246.00 259.76 1932.00 929.00 107.97 1349.00 709.00 90.27
PBDT 5064.00 3599.00 40.71 17859.00 11733.00 52.21 16426.00 21396.00 -23.23
Depreciation 1216.00 1200.00 1.33 3687.00 3559.00 3.60 4787.00 4511.00 6.12
PBT 3848.00 2399.00 60.40 14172.00 8174.00 73.38 11639.00 16885.00 -31.07
TAX 1289.00 429.00 200.47 3787.00 2064.00 83.48 3060.00 2123.00 44.14
Deferred Tax 427.00 183.00 133.33 465.00 241.00 92.95 458.00 -910.00 -150.33
PAT 2559.00 1970.00 29.90 10385.00 6110.00 69.97 8579.00 14762.00 -41.88
Equity 1012.00 1024.00 -1.17 1024.00 1024.00 0.00 1024.00 1024.00 0.00
PBIDTM(%) 28.51 21.01 35.70 30.60 26.59 15.10 26.27 30.82 -14.77

Zydus Lifesciences Share Price

942.40 -0.15 (-0.02%)
20-Apr-2026 12:56 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1670.35
Dr. Reddys Lab 1236.85
Cipla 1232.80
Zydus Lifesciences 942.40
Lupin 2332.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×